Kadcyla 160 mg Injection

Get a Price/Quote

MOQ : 1 Piece

Kadcyla 160 mg Injection Specification

Origin of Medicine
Switzerland

Physical Form
Powder

Recommended For
DOCTOR

Quantity
1 Pieces

Color
White to off-white

Packing Type
Vial

Type
Anticancer injection

Strength
160 mg

Route of Administration
Intravenous

Kadcyla 160 mg Injection Trade Information

Minimum Order Quantity
1 Piece

Delivery Time
1 Week

About Kadcyla 160 mg Injection

Kadcyla 160 mg injection is a targeted therapy designed for individuals diagnosed with specific types of breast cancer, particularly those characterized by high levels of the HER2 protein. This innovative medication combines a monoclonal antibody with a microtubule inhibitor, effectively delivering treatment directly to cancer cells while minimizing damage to healthy tissues. By binding to the HER2 protein on cancer cells, Kadcyla disrupts their growth and proliferation, offering a strategic approach to combatting aggressive breast cancer. Patients should be aware of potential side effects, including fatigue, nausea, and infusion-related reactions, which necessitate close monitoring during treatment. Its essential to discuss any pre-existing health conditions and medications with your healthcare provider prior to starting Kadcyla to ensure safe administration. With its targeted action, Kadcyla is paving the way for more personalized cancer treatments, giving hope to those affected by HER2-positive breast cancer. Always consult with your oncologist to determine if Kadcyla is the right choice for your specific situation.

How Does Kadcyla 160 mg Injection Work?

Kadcyla 160 mg Injection is a targeted therapy that combines the HER2-targeted properties of trastuzumab with a chemotherapy agent (DM1). Once administered intravenously, the medication attaches to HER2-positive cancer cells and delivers chemotherapy directly into them, causing their destruction while limiting damage to healthy tissue.

When Should Kadcyla 160 mg Injection Be Administered?

Kadcyla is primarily used after prior treatment with trastuzumab and chemotherapy in individuals with HER2-positive breast cancer. The specific schedule is determined by a doctor, typically every three weeks, and is based on the patient's individual medical profile and response to therapy.

Benefits of Kadcyla 160 mg Injection

Kadcyla offers dual action against cancer by targeting cancer cells more specifically, which can result in improved treatment outcomes and potentially fewer side effects compared to standard chemotherapy. It is a trusted choice globally, with its Swiss origin providing an additional assurance of quality.

FAQ's of Kadcyla 160 mg Injection:

Q: How should Kadcyla 160 mg Injection be administered?

A: Kadcyla 160 mg Injection is administered by a medical professional through intravenous infusion. The powder is first reconstituted, then diluted, and infused directly into a patient's bloodstream under hospital or clinic supervision.

Q: What is the main use of Kadcyla 160 mg Injection?

A: Kadcyla 160 mg Injection is primarily used in the treatment of HER2-positive breast cancer, especially when other therapies like trastuzumab and chemotherapy alone have already been tried.

Q: When is the Kadcyla 160 mg Injection given during cancer treatment?

A: Kadcyla is typically administered after the patient has completed other HER2-targeted therapies and chemotherapy, as per the recommendation of the treating doctor.

Q: Where can healthcare providers obtain Kadcyla 160 mg Injection in India?

A: This injection is available through authorized distributors, exporters, suppliers, traders, and wholesalers throughout India, with distribution strictly limited to licensed medical institutions.

Q: What is the process for preparing and using Kadcyla 160 mg Injection?

A: A healthcare provider will reconstitute the white to off-white powder with sterile water before further diluting and administering it by intravenous infusion. Strict aseptic techniques and dosing protocols are always followed.

Q: What are the potential benefits of using Kadcyla 160 mg Injection over conventional chemotherapy?

A: Kadcyla targets and destroys cancer cells more specifically with reduced harm to healthy tissue, often resulting in improved outcomes and fewer adverse effects compared to conventional chemotherapy protocols.

Tell us about your requirement